The Asia Pacific Consortium on Osteoporosis (APCO) comprises Osteoporosis experts from several countries in Asia Pacific, charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention in this most populated and fastest-growing region of the world.
Over the years, APCO has developed several resources such as the APCO Framework, the Bone Health QI Tool Kit, the HCP Peer-to-Peer Education Modules, and the APCO Collective Intellect Clinical Case Discussion Platform (CICCDP). To learn more about APCO, click here.
Registration is limited to the first 150 people
Connect with top experts, peers, and scientific influencers, fostering collaborations and building lasting professional relationships.
1Engage in scientific sessions that offer practical insights and skills applicable to clinical practice.
2Showcase commitment to the field, potentially leading to opportunities for recognition, publications, and career development within the field.
3Access the latest research and breakthroughs in areas such as advanced musculoskeletal imaging, artificial intelligence, and machine learning in osteoporosis.
4Registration is limited to the first 150 people
The OE course which will provide in depth understanding of the principles of bone densitometry and management of osteoporosis will be especially useful for all health care practitioners including specialists, general practitioners, nurses, technologists, and other allied health care professionals working in the bone health field. Trainees and medical students will also benefit immensely from this course.
1The Metabolic Bone Disease Symposium (Main Congress) is best suited for Clinicians and Trainees with a special interest in the management of all metabolic bone diseases. Though we welcome all clinicians, the main congress will thus be most useful for clinicians and trainees from the disciplines of Adult and Pediatric Endocrinology, Rheumatology, Nephrology, Internal Medicine, Orthopaedics, and Geriatrics.
2Singapore
APCO Executive Committee Chair and Chairperson, Scientific Committee, SOOMBODS
Senior Consultant and Director, Osteoporosis and Bone Metabolism Unit
Singapore General Hospital
Malaysia
Consultant Endocrinologist, Puchong Medical Specialist Centre, Subang Jaya Medical Centre
Hong Kong
CEO of the Hong Kong Center for Clinical Research and the Consultant of the Hong Kong Orthopaedic and Osteoporosis Center. Founding President of the Asian Pacific Osteoporosis Foundation
Singapore
Senior Consultant, Division of Rheumatology, Department of Medicine, National University Hospital, Singapore
Sri Lanka
India
Endocrinologist and the Chairman and Head of Endocrinology and Diabetes at Max Healthcare, Saket, New Delhi, India
Japan
Myanmar
Thailand
Orthopedic Surgeon, Bhumibol Adulyadej Hospital
President-elect, Metabolic Bone Disorder and Orthogeriatrics Society
Singapore
APCO Executive Committee Chair and Chairperson, Scientific Committee, SOOMBODS
Senior Consultant and Director, Osteoporosis and Bone Metabolism Unit
Singapore General Hospital
Switzerland
Australia
Head of the Department of Medicine in the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences
Germany
Professor of Medical Physics, Department of Diagnostic Radiology, Christian-Albrechts-Universität zu Kiel (CAU), Germany
Switzerland
Head of Research and Development, Bone and Joint Department, Centre for Bone Diseases, Lausanne University Hospital
Malaysia
Consultant Endocrinologist, Puchong Medical Specialist Centre, Subang Jaya Medical Centre
Hong Kong
CEO of the Hong Kong Center for Clinical Research and the Consultant of the Hong Kong Orthopaedic and Osteoporosis Center. Founding President of the Asian Pacific Osteoporosis Foundation
Singapore
Senior Consultant, Division of Rheumatology, Department of Medicine, National University Hospital, Singapore
United Kingdom
Professor of Adult Bone Diseases, Mellanby Centre for Musculoskeletal Research, University of Sheffield
Director, Medical Research Council Versus Arthritis Centre for Integrated research in Musculoskeletal Ageing
India
Endocrinologist and the Chairman and Head of Endocrinology and Diabetes at Max Healthcare, Saket, New Delhi, India
Belgium
Director and Professor, Department of Public Health, Epidemiology and Health Economics, University of Liège
Director of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
South Korea
Professor, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine
Japan
Myanmar
Thailand
Orthopedic Surgeon, Bhumibol Adulyadej Hospital
President-elect, Metabolic Bone Disorder and Orthogeriatrics Society
Singapore
Senior Consultant, Department of Paediatric Medicine, Endocrine Service, KK Women's and Children's Hospital, Singapore
JOIN US FOR THE
The Osteoporosis Essentials course will teach learners, including Specialists, General Practitioners (GPs), nurses, and pharmacists advanced skills to screen for, diagnose and treat Osteoporosis most effectively.
The Metabolic Bone Disorders symposium (Main Congress) part of the Summit will be dedicated to the discussion and presentation of several metabolic bone diseases including osteoporosis, as well as rare genetic skeletal disorders in both children and adults. We are proud to have internationally acclaimed faculty speak at the Congress.
Chairs: Prof Manju Chandran and Dr Philippe Halbout
Panoramic view of Osteoporosis management over the last 30 years - from the view point of a clinician, researcher and epidemiologist - Prof. J-Y Reginster
Chair: Prof Eugene McCloskey
14.55 - 15.30 - Understanding the vitamin D trials- Decisive Verdict or Persistant Uncertainties -
Prof Ambrish Mithal
15.30 - 15.55 - Current Anabolic therapies and those on the Horizon - Prof Peter Ebeling
15.55 - 16.20 - Sequential and Combination Therapy: The Knowns and the Unknowns - Prof Edith Lau
16.20 - 16.35 - Q&A - Session 1 Speakers
Coffee/Tea and snacks will be served in Foyer area. We invite all participants to visit the Exhibition area during the break
Chairs: Prof Didier Hans and Prof Edith Lau
1. A multicenter, randomized, active-controlled, double-blinded, parallel-group, phase 3 study to compare the efficacy, safety, immunogenicity and pharmacokinetics of biosimilar teriparatide 20 μg versus reference teriparatide 20 μg in patients of postmenopausal osteoporosis. - Dr Dr Nitin Kapoor (India)
2. TLR4 gene polymorphism and biochemical markers as a tool to identify risk of osteoporosis in women from Karachi - Ms Rozeena Baig (Pakistan)
3. Reference Ranges for Trabecular Bone Score in Vietnam: The Vietnam Osteoporosis Study - Dr Minh Doan Cong (Vietnam)
4. DXA derived sideways fall model: A tool to assess hip fracture risk and efficacy of prevention interventions - Mr Dheeraj Jha (Singapore)
5. FRAX-Based Intervention Thresholds For Bangladesh - Dr Lakshmi Nagendra (India)
6. Bridging osteoporotic fracture management: leveraging opportunistic CT imaging and advanced risk assessment technologies - Dr Anitha D Praveen (Singapore)
Chair: Prof Ambrish Mithal
17.55 - 18.30 - Pharmacotherapy of Rare Bone Disorders: Heralding a New Era - Prof Manju Chandran
18.30 - 18.55 - Phosphate Wasting Disorders for the Metabolic Bone Clinician. Identifying and Treating before it is too late - Prof Yumie Rhee
18.55 - 19.05 - Q&A - Session 2 Speakers
19.05 - 19.20 - Rare Bone Disease - Advocacy across the AP Region - Where Do We Stand - Mr Rajakanth
Networking dinner will be served in the Foyer area. We invite all participants to visit the Exhibition and Poster area during the evening.
Chair: Prof Peter Ebeling
08.05 - 08.45 - Choosing a Treatment Threshold for Osteoporosis. Why the confusion? -
Prof Eugene McCloskey
08.45 - 09.15 - Handling Side effects associated with osteoporosis therapy-Atypical fractures and Osteonecrosis of the Jaw -
Dr Hew Fen Lee
09.15 - 09.25 - Q&A
09.25 - 09.55 - Osteoporosis in Renal failure - Dr Wong Jiunn
09.55 - 10.25 - Optimizing bone health before orthopaedic surgery - Dr Thanut Valleenukul
10.25 - 10.35 - Q&A - All Speakers
Coffee/Tea and snacks will be served in Foyer area. We invite all participants to visit the Exhibition area during the break
Chair: Prof Ambrish Mithal
11.00 - 11.35 - Artificial Intelligence in Osteoporosis. The future is here - Prof Claus Gluer
11.35 - 12.05 - Advanced Imaging in Osteoporosis: 3D Shaper, TBS, HRpQCT - Prof Didier Hans
12.05 - 12.35 - Bone fragility other than due to Osteoporosis : Osteoegenesis Imperfecta - Dr Rashida Vasanwala
12.35 - 12.45 - Q&A - All speakers
Chair: Prof Tet Tun Chit
13.50 - 14.05 - Future proofing against the second fracture: Capture the Fracture® Global Overview -Dr Philippe Halbout
14.05 - 14.25 - The success story of the Capture the Fracture® Global Program in Japan - Dr Atsushi Suzuki
Chair: Prof Manju Chandran
14.25 - 15.10 - The APCO Golden Dragon Debate 2024 : Topic: Osteoporosis Management in a low resource environment is an impossible task
Debaters: Adj. Prof Lau Tang Ching and Prof Eugene McCloskey
Coffee/Tea and snacks will be served in Foyer area. We invite all participants to visit the Exhibition area during the break
Moderator: Adj Prof Lau Tang Ching
15.30 - 16.20 - The APCO Collective Intellect Clinical Case Discussion Platform (CICCDP): May 2024 Edition -
Panelists: Prof Manju Chandran, Prof Peter Ebeling, Prof Ambrish Mithal
16.20 - 16.30 - Q&A
16.30 - 16.40 - Wrap Up and Close
Deadline for Early Bird Registration is 25 March 2024. Registration is limited to the first 150 people
OE COURSE ONLY | CONGRESS ONLY | OE COURSE & CONGRESS | |
---|---|---|---|
Incl. delegate bag, Osteoporosis Essentials manual, 3 coffee breaks, and a lunch | Incl. delegate bag, E-program book, 3 coffee breaks, a lunch and a networking dinner | Incl. delegate bag, Osteoporosis Essentials manual, Congress E-program book, 6 coffee breaks, 2 lunches and a networking dinner | |
STANDARD DELEGATES | USD 340 | USD 325 | USD 580 |
TRAINEE OR LOWER-MIDDLE INCOME COUNTRIES* | USD 265 | USD 255 | USD 450 |
Registration is limited to the first 150 people